EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort

• Главные авторы: Qintao Ge (Автор), Jiawei Li (Автор), Junyue Tao (Автор), Rui Gao (Автор), Chen Jin (Автор), Jun Zhou (Автор), Meng Zhang (Автор), Zongyao Hao (Автор), Jialin Meng (Автор), Chaozhao Liang (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

EPM2A encodes a dual specificity phosphatase and has been proven to be a potential biomarker in several cancers but has not been mentioned in prostate cancer (PCA). We investigated the prognostic and therapeutic value of EPM2A in PCA. The TCGA-PRAD cohort was collected to evaluate the differential e...